risks of glp 1 agonists Adverse Effects GLP-1 Receptor Relative effects of glucagon-like peptide-1

The CRP levels were significantly higher in the placebo group compared to LCLT group at day 21 (Table 2)

NCI Monogr 1988

Not recommended during pregnancy or breastfeeding without medical advice

What most patients don't realise: the nausea isn't random

A final alternative to alleviate FcRn-controlled pathological mechanisms could be to alter FcRn in itself, as may be intended with a gene therapy being developed in a collaboration between Beam and Apellis for a one-time dose of gene-editing molecules targeting FcRn [436, 437]

It is common for patients to come in after travel, long workdays, or when they simply feel depleted and want to support their body more intentionally